181 filings
8-K
FEMY
Femasys Inc
24 Apr 24
Regulation FD Disclosure
9:11am
S-8
FEMY
Femasys Inc
5 Apr 24
Registration of securities for employees
5:17pm
S-8
FEMY
Femasys Inc
5 Apr 24
Registration of securities for employees
5:07pm
10-K
2023 FY
FEMY
Femasys Inc
Annual report
28 Mar 24
5:05pm
8-K
FEMY
Femasys Inc
28 Mar 24
Results of Operations and Financial Condition
4:23pm
8-K
FEMY
Femasys Inc
20 Mar 24
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
8:18am
8-K
FEMY
Femasys Inc
6 Mar 24
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
9:09am
8-K
FEMY
Femasys Inc
28 Feb 24
Disrupting Convention in Women’s Health Through Continuous Innovation February 2024 Corporate Presentation 1
9:16am
4
Richard D. Spector
13 Feb 24
FEMASYS / Richard D. Spector ownership change
9:47pm
3
Richard D. Spector
13 Feb 24
FEMASYS / Richard D. Spector ownership change
9:44pm
8-K
FEMY
Femasys Inc
6 Feb 24
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
8:47am
4
FEMY
Femasys Inc
2 Feb 24
FEMASYS / Daniel Scott Currie ownership change
4:43pm
4
Dov Elefant
2 Feb 24
FEMASYS / Dov Elefant ownership change
4:43pm
4
Christine E Thomas
2 Feb 24
FEMASYS / Christine E Thomas ownership change
4:42pm
4
Kathy Lee-Sepsick
2 Feb 24
FEMASYS / Kathy Lee-Sepsick ownership change
4:42pm
EFFECT
FEMY
Femasys Inc
11 Dec 23
Notice of effectiveness
12:15am
424B3
FEMY
Femasys Inc
8 Dec 23
Prospectus supplement
9:28am
CORRESP
FEMY
Femasys Inc
6 Dec 23
Correspondence with SEC
12:00am
UPLOAD
FEMY
Femasys Inc
5 Dec 23
Letter from SEC
12:00am
S-3
FEMY
Femasys Inc
Shelf registration
30 Nov 23
5:17pm